Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
Clinical trial NCT02442778 · COMPLETED
Trial details
- NCT number
- NCT02442778
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-11
- Primary completion
- 2019-08-14
- Enrollment
- 522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.